Isolated Growth Hormone Deficiency, Type Iii; Ighd3
Genes related to Isolated Growth Hormone Deficiency, Type Iii; Ighd3
- BTK
Clinical Features
Top most frequent phenotypes and symptoms related to Isolated Growth Hormone Deficiency, Type Iii; Ighd3
- Short stature
- Hearing impairment
- Diarrhea
- Immunodeficiency
- Delayed skeletal maturation
- Pneumonia
- Decreased antibody level in blood
- Growth hormone deficiency
- Recurrent urinary tract infections
- Sinusitis
And another 14 symptoms. If you need more information about this disease we can help you.
Incidence and onset information
— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)— No data available about the known clinical features onset.
Alternative names
Isolated Growth Hormone Deficiency, Type Iii; Ighd3 Is also known as hypogammaglobulinemia and isolated growth hormone deficiency, x-linked, ighd iii, fleisher syndrome, agammaglobulinemia and isolated growth hormone deficiency, x-linked, growth hormone deficiency with hypogammaglobulinemia.
Researches and researchers
Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.Isolated Growth Hormone Deficiency, Type Iii; Ighd3 Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
GeneAware Complete Panel Version 2 (Female).
By Baylor Miraca Genetics Laboratories (United States).
RMRP, BCS1L, SACS, BLM, SGCA, SGCB, SGCG, SGSH, SLC12A6, SLC17A5, SLC22A5, SLC25A13, SLC25A15, SLC26A2, SLC35A3, SLC7A7, SMN1, SMPD1, BTD, BTK , (...)
View the complete list with 139 more genes
Specificity
1 %
Genes
100 % |
X-Linked Agammaglobulinemia.
By Clinical Molecular Genetics Laboratory Johns Hopkins All Children's Hospital (United States).
BTK
Specificity
100 %
Genes
100 % |
X-linked Agammaglobulinemia (XLA): BTK (Full Gene Sequencing).
By Molecular Diagnostic Laboratory University of Alberta (Canada).
BTK
Specificity
100 %
Genes
100 % |
X-linked Agammaglobulinemia (XLA): BTK (Known Mutation).
By Molecular Diagnostic Laboratory University of Alberta (Canada).
BTK
Specificity
100 %
Genes
100 % |
BTK Deletion/duplication analysis.
By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center (United States).
BTK
Specificity
100 %
Genes
100 % |
BTK Sequencing.
By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center (United States).
BTK
Specificity
100 %
Genes
100 % |
Primary Antibody Deficiency Panel, Sequencing and Deletion/Duplication.
By ARUP Laboratories, Molecular Genetics and Genomics (United States).
SH2D1A, BTK, CD40, CD40LG, UNG, VAV1, AICDA, BLNK, CD19, CD79A, CD79B, CD81, LRBA, TNFRSF13C, TNFRSF13B, ADA, LRRC8A, CR2, ICOS, IGHM , (...)
View the complete list with 15 more genes
Specificity
3 %
Genes
100 % |
BTK. MLPA testing.
By Instituto de Medicina Genomica Instituto de Medicina Genomica (Spain).
BTK
Specificity
100 %
Genes
100 % |
You can get up to 71 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
OMIM ORPHANET Genetic Syndrome FinderIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like COMPLEMENT COMPONENT 8 DEFICIENCY, TYPE I; C8D1 HEREDITARY PHEOCHROMOCYTOMA-PARAGANGLIOMA COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH MOYAMOYA DISEASE 6 WITH ACHALASIA; MYMY6 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1A; LGMD1A